Company Overview and News

 
Oswal Greentech sells 16.66 lakh shares of Monnet Ispat

2018-01-10 moneycontrol
On January 9, 2018 Oswal Greentech sold 16,66,389 shares of Monnet Ispat at Rs 33.66 on the NSE.

 
Oswal Greentech sells 16.29 lakh shares of Monnet Ispat

2018-01-09 moneycontrol
On January 8, 2018 Oswal Greentech sold 16,29,889 shares of Monnet Ispat at Rs 33.62 on the NSE.

 
Trade setup for Tuesday: Top 15 things you should know before Opening Bell

2018-01-08 moneycontrol
The Nifty which started with a gap on the higher side rose to a fresh record high of 10,631.20 in morning trade on Monday and made a small bull candle on the daily candlestick charts.

 
Oswal Greentech sells 13 lakh shares of Monnet Ispat

2017-12-31 moneycontrol
On December 29, 2017 Oswal Greentech sold 13,09,593 shares of Monnet Ispat at Rs 35.52 on the NSE.

 
Oswal Greentech sells 62.85 lakh shares of NDTV

2016-08-30 moneycontrol
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

 
LTS Investment buys 10% stake in NDTV via bulk deal

2016-08-29 thehindubusinessline
Shares of New Delhi Television soared as much as 17.25 per cent intraday on the NSE as foreign institutional investor LTS Investment Fund bought 9.75 per cent stake or 62.85 lakh shares in the company from Oswal Greentech at ₹81 a share aggregating to ₹50.9 crore.

 
Pankaj Oswal sends notice to mother, others

2016-04-25 thehindubusinessline
The family dispute in the Oswal Group has deepened with Pankaj Oswal serving a legal notice seeking to freeze all assets, including bank accounts, properties and shares owned by the late businessman Abhey Oswal. Pankaj Oswal is the eldest son of the late businessman.

 
Pankaj Oswal told not to leave Australia by tax authorities

2016-04-23 freepressjournal.in
Sydney : Amid a takeover tussle with his mother for control of Oswal Greentech and Oswal Agro Mills, Pankaj Oswal has been ordered by authorities in Australia not to leave the country due to a taxation case involving millions of dollars, reports PTI.

 
Oswal vs Oswal

2016-04-15 business-standard
On April 2, the directors of Oswal Agro Mills and Oswal Greentech met at the 7th floor of Antriksh Bhawan, a high-rise in the Connaught Place area of New Delhi. On the agenda was the appointment of a new director and chairman: Aruna Oswal. These meetings were called after Aruna's husband and the chairman of the two companies, Abhey Oswal, had died in Moscow four days ago. The mood was sombre, the meetings were short.

 
My mother is being misled by mischievous folks around her: Pankaj Oswal

2016-04-09 business-standard
A bitter succession battle has broken out in the Oswal family after the death of Abhey Kumar Oswal last month. Allegations and counter allegations are flying thick and fast as Oswal's eldest son, Pankaj Oswal, has challenged his mother's appointment to the board of group companies - Oswal Greentech and Oswal Agro Mills. On the other hand, the companies have filed a police complaint against him for alleged stealing of documents.

 
More charges in Oswal family battle

2016-04-08 business-standard
BS REPORTER  |  A statement was issued on behalf of the former that a police case had been filed against Pankaj Oswal  April 9, 2016 Last Updated at 00:39 IST

 
Abhey Oswal wanted his wife to succeed him at Co:Oswal Greentech

2016-04-08 moneycontrol
Anil Bhalla, MD, Oswal Greentech in an interview to CNBC-TV18 said Aruna Oswal was a capable person to run the company and Abhey also wanted his wife to succeed him at the company and she was his nominee.

 
Stocks in news: Cairn, NMDC, Ipca Lab, Sagar Cement, RComm, NBCC

2016-04-08 moneycontrol
Cairn India | NMDC | Ipca Labs | Adani Enterprises | Sagar Cement | NBCC | IVRCL | PNC Infratech | Jyoti Structures | Simplex Projects and Reliance Communications are stocks, which are in the news today.

 
Succession battle in Oswal group

2016-04-07 business-standard
Sanjeeb Mukherjee & N Sundaresha Subramanian  |  New Delhi  April 8, 2016 Last Updated at 00:35 IST

 
Abhey Oswal: A man of multiple interests

2016-04-01 business-standard
In the 1980s, Abhey Oswal was known as the ‘next Ambani. He was market-savvy and had a knack of taking over businesses and also building them from ground. The Ambani reference would refuse to go away, even in the last months of his life.     Oswal, 67, passed away after a heart attack on Tuesday, in Moscow, where he had gone to market some medicines developed by one of his multiple ventures. He is survived by wife Aruna Oswal, who is engaged philanthropic activities through Aruna & Abhey Oswal Trust, sons Pankaj and Shail and daughter Shallu.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

22h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...